Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

However, Karp's exuberance about Palantir's Q3 results is warranted. The company blew past the consensus Wall Street revenue estimate of $1.09 billion. Its revenue growth accelerated from a 48% year ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...

ASCO discussant Krina Patel, MD, of the University of Texas MD Anderson Cancer Center in Houston, noted, "Ciltacabtagene ...

Latin America faces a productivity crisis as industry declines and exports revert to raw materials, according to new ECLAC ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Timothy Li is a ...

Sana Biotechnology (SANA) shares have been trending higher over the past month, recording a 47% gain. This upward move comes as investors sort through recent developments and assess the company’s ...

Investing.com -- Sana Biotechnology Inc (NASDAQ:SANA) stock surged 20% Wednesday after EMJ Capital Eric Jackson declared the company could become "the next 100-bagger platform" in a series of posts on ...

The launch of Rockcliffe Labs follows its acquisition of Algae-C Inc. , a biotechnology company with 14 patents and over 600 ...

Oct. 28, 2025 — Fungi’s evolutionary roots stretch far deeper than once believed — up to 1.4 billion years ago, long before plants or animals appeared. Using advanced molecular dating and gene ...

Investing.com -- Sana Biotechnology Inc (NASDAQ:SANA) stock surged 20% Wednesday after EMJ Capital Eric Jackson declared the company could become "the next 100-bagger platform" in a series of posts on ...